WCM-Q clinician scientist ranked number one medical researcher in Qatar for third year running
The Research.com list also ranked Dr. Malik among the top 10,000 researchers in medicine in the world, placing him at number 8,350. The ranking is based on an analysis of the number of influential pieces of research authored by the scientist, combined with awards, fellowships and academic recognition they have received from leading research institutions and government agencies. To date, Dr. Malik has published 729 scientific papers, and his work has been cited 40,188 times. The majority of his research (over 350 papers) has been published since he joined WCM-Q from the University of Manchester, UK in June 2014.
Dr. Malik said: 'Our clinical research program is now recognized internationally, with Qatar ranking second in the world for publications in diabetic neuropathy, with a Relative Publication Output per capita (RPOP) of 18.01 publications per inhabitant. I am very grateful for the support from WCM-Q and the investment in research infrastructure made by Qatar Foundation and the Ministry of Public Health.'
Dr. Malik added: 'According to the Global Burden of Disease study published in Lancet Neurology in 2024, neurodegenerative diseases affect 3.4 billion people across the world and diabetic neuropathy, characterized by pain, numbness and ulcers with lower leg amputation, has witnessed the biggest increase (92%) in disability-adjusted life years (DALYs) from 1990 to 2021. The key to improving patient's lives with neurodegenerative diseases is earlier diagnosis and treatment.'
With this as a key focus, Dr. Malik and his team have pioneered use of the Corneal Confocal Microscope (CCM), a rapid eye scan to diagnose and predict progression of diabetic neuropathy, Parkinson's disease, multiple sclerosis, dementia, schizophrenia and autism, among other conditions.
Dr. Malik also said: 'Our clinical research program could not have been so successful without our very positive collaborations with clinicians and researchers in major healthcare institutions across Qatar, including diabetes and endocrinology and neurology and the Clinical Trials Unit in Hamad Medical Corporation; endocrinology and gastroenterology in Sidra Medicine and several key departments in Hamad Bin Khalifa University and Qatar University.'
About Weill Cornell Medicine-Qatar
Weill Cornell Medicine-Qatar is a partnership between Cornell University and Qatar Foundation. It offers a comprehensive Six-Year Medical Program leading to the Cornell University M.D. degree with teaching by Cornell and Weill Cornell faculty and by physicians at Hamad Medical Corporation (HMC), Sidra Medicine, the Primary Health Care Corporation, and Aspetar Orthopedic and Sports Medicine Hospital, who hold Weill Cornell appointments. Through its biomedical research program, WCM-Q is building a sustainable research community in Qatar while advancing basic science and clinical research. Through its medical college, WCM-Q seeks to provide the finest education possible for medical students, to improve health care both now and for future generations, and to provide high quality health care to the Qatari population.
For more info, please contact:
Hanan Lakkis
Associate Director, Media and Publications
Weill Cornell Medicine - Qatar
hyl2004@qatar-med.cornell.edu
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
2 hours ago
- Zawya
Hamdan bin Rashid Al Maktoum Foundation Concludes 2025 Summer Camp for Gifted Students under the Theme "Skills of Tomorrow"
Dubai World Trade Centre, Dubai, UAE: Hamdan bin Rashid Al Maktoum Foundation for Medical and Educational Sciences, has concluded the 2025 Summer Camp for Talent and Innovation, held under the theme "Skills of Tomorrow". The camp welcomed the participation of over 130 gifted and innovative students from across the UAE, offering an advanced educational environment designed to cultivate future skills, foster innovative thinking, and strengthen leadership qualities among participants. Dr Mariam Al Ghawi, Director of Hamdan bin Rashid Al Maktoum Centre for Giftedness and Innovation, commented: "We were committed to creating a stimulating learning environment for talented and innovative students during the summer break—one that helped develop their skills, sharpen their capabilities, and provided hands-on exposure to technological and innovation-based concepts in real-world contexts. The level of engagement and creativity we witnessed from students throughout the camp represents a message of hope for a brighter future, one driven by promising national talents equipped with knowledge and a spirit of leadership. We look forward to building on this momentum in future editions by expanding strategic partnerships and enriching both theoretical and practical content in line with national aspirations. The outcomes achieved this year are a clear reflection of the dedicated efforts of our teams and strategic partners and underscore the Foundation's success in establishing a comprehensive educational model that links talent with innovation." Dr. Al Ghawi also expressed appreciation for the valuable partnerships with key supporting entities, notably Dubai Culture and Arts Authority, DP World, Expo Dubai, and Thukher Club, emphasizing that these collaborations form a core pillar of the camp's impact and sustainability. Over the course of two weeks, the camp delivered 12 specialized training programs covering advanced knowledge and technology fields, including artificial intelligence, smart cities, the Internet of Things, digital design, and robotics. The agenda also featured hands-on workshops and high-impact field visits, most notably a scientific visit to the Terra Pavilion at Expo Dubai and an exploratory program at Dubai Maritime City—offering participants unique opportunities to engage in experiential learning. In addition, the camp extended its activities to include awareness programs for parents and senior citizens, further reinforcing the initiative's community and educational dimensions. The camp reflects the Foundation's ongoing commitment to supporting and empowering gifted students, and to developing human capital in the UAE through comprehensive educational initiatives informed by international best practices. It also aligns with the Foundation's vision to establish a sustainable national framework for talent discovery and development, in line with the UAE Centennial 2071 goals of building a competitive knowledge-based economy and an innovation-driven society. The camp concluded with a special recognition ceremony for participating students, during which certificates of achievement were distributed and student-led projects and innovations were showcased—demonstrating a high level of creative thinking and the ability to apply technical knowledge to develop real-world solutions for future challenges.
Emirates 24/7
3 hours ago
- Emirates 24/7
Dubai Health scientists publish first Arab Pangenome Reference, marking a milestone for precision medicine
Scientists at the Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), the learning and discovery arm of Dubai Health, have published the first Arab Pangenome Reference, marking a major milestone in both regional and global genomic research. The study, released in Nature Communications, a leading scientific journal, provides a crucial foundation for advancing precision medicine and personalised healthcare for Arab populations, while also supporting the UAE's National Genome Strategy, a 10-year initiative launched in 2023 by the Emirates Genome Council to advance personalised, preventive, and precision healthcare through cutting-edge genomic science. The reference was built using high-quality DNA sequencing from 53 people of diverse Arab backgrounds in the UAE. The work, conducted in MBRU's state-of-the-art Center for Applied and Translational Genomics (CATG), uncovered over 110 million base pairs of novel DNA sequences and identified nearly nine million small differences and more than 235,000 larger structural differences specific to Arab populations that have not been reported before. These findings are significant, as global DNA references have historically underrepresented Arab populations — a gap this research helps to close. The Arab Pangenome Reference supports national and regional precision medicine initiatives by enabling the development of population-specific biomarkers, risk models, and therapeutic targets. One notable discovery was the duplicated gene TAF11L5, found highly enriched in Arab individuals studied but absent from global references. This gene may play a role in regulating other genes and could have implications for understanding disease risk and individual variation in treatment response. Professor Alawi Alsheikh-Ali, Director General, Dubai Health Authority, and co-author of the study, said: 'This achievement strengthens the UAE's position in genomic science. By building a reference that reflects the genetic diversity of Arab populations, we are enabling more precise and equitable healthcare. It's a foundational step towards realising the goals of our National Genome Strategy and ensuring that future medical innovations are shaped by data from our own communities.' Dr. Hanan Al Suwaidi, Acting Provost of MBRU, and co-author of the study said: 'The capabilities of the CATG lab were central to the success of this project. From genetic sequencing to advanced bioinformatics, every stage of the research was completed in-house. This level of integration gave us full control over quality and timelines, reflecting Dubai Health's commitment to building world-class infrastructure and fostering national scientific leaders." While genomic research has advanced rapidly over the past two decades, much of the foundational data has come from a narrow subset of global populations. This has created blind spots in how genetic risk is understood and addressed across different communities. The Arab Pangenome Reference contributes to a growing international effort to correct this imbalance by introducing high-quality data from a historically underrepresented population. Dr. Mohammed Uddin, Director of CATG and Associate Professor of Genetics at MBRU, and senior author of the study, said: 'This pangenome reference marks a major advancement in our understanding of Arab genomic diversity. It serves as a critical resource for both research discovery and clinical genome diagnostics, with lasting impact for future generations across the region.' The project also developed 'PanScan', a bioinformatics tool to support more complex analysis of human pangenomes. Although not the central focus of the study, PanScan enables researchers to detect gene duplications, novel DNA changes, and complex DNA structures. Now publicly available on GitHub, a common resource used by scientists worldwide, the tool was created to support the Arab Pangenome Reference and similar efforts globally. Dr. Nasna Nassir, lead author of the study and Assistant Professor at MBRU, said: 'To support the Arab Pangenome Reference study, we developed PanScan, a tool designed to identify novel variants, gene duplications, and complex haplotype patterns specific to Arab populations. PanScan was key to uncovering unique genomic insights in our study and is now publicly available to support similar research globally.' The research reflects Dubai Health's commitment to advancing learning and discovery through MBRU. The university's research strategy is focused on contributing to global scientific progress. By investing in foundational genomic research, Dubai Health is helping to ensure that Arab populations are represented in the future of precision healthcare. The full study is available at:
Zawya
5 hours ago
- Zawya
"Colors of Hope Initiative": Yas Clinic Hospital and Abu Dhabi Stem Cells Center transform Pediatric Bone Marrow Transplant unit into an artwork of hope for young patients and their families
Abu Dhabi: Within the healing walls of Yas Clinic Hospital and the Abu Dhabi Stem Cells Center, care, hope and dream now radiate from every surface of the pediatric Bone Marrow Transplant (BMT) unit. The newly inaugurated 'Colors of Hope' project is more than a collection of paintings; it's a heartfelt mission to surround every young patient, their family, and dedicated caregivers with an atmosphere of inspiration and boundless possibility. Stepping into the Bone Marrow Transplant unit takes you on an exciting journey painted across walls, a world compassionately envisioned by the Cente's and hospital leadership team, who echo their mission of providing latest innovative solution that inspire hope and confidence in our future. Brought to life by Emirati artist Mariam AlHarthi, a Yas Clinic employee. Their goal: transform the experience of serious illness into a celebration of courage and imagination, where each child is seen as a future leader, scientist, explorer, or artist. The vibrant paintings and artwork that decorate the walls of the Bone Marrow Transplant unit are inspired by the remarkable achievements and culture of the United Arab Emirates. These paintings plant seeds of confidence in young hearts, assuring each child that their dreams are possible, no matter the challenges they might face. In these halls, laughter mingles with hope, resilience sparks children's imagination, and above all, hope becomes the strongest medicine of all. Dr. Fatema Al Kaabi, Executive Director of the Bone Marrow Transplant Program at Yas Clinic Hospital and Abu Dhabi Stem Cells Center, shared: 'Every color that brightens the walls of our pediatric bone marrow transplant unit reflects a powerful strength I witness daily in our young patients and in our medical team at Yas Clinic Hospital and Abu Dhabi Stem Cells Center. My ongoing wish is that these vibrant paintings breathe new hope into children as they go through their treatment. Each painting is a promise to our children and their families that their dreams will always be treasured in our hearts. Hope is the bridge that carries families and care teams over every challenge. Through art and imagination, we strengthen each child's resolve and celebrate a unique journey toward healing.' The "Colors of Hope" initiative is part of the UAE's national "Year of Community," demonstrating how Yas Clinic Hospital and Abu Dhabi Stem Cells Center bring together art and community spirit to enhance the care of young patients. These paintings are far more than simple decorations, they are a living honour to healing, hope, and the unity of the Emirati community in all its diversity. Here, patients, families, and caregivers walk the healing journey together, hand in hand. Dr. Mansi Sachdev, Consultant in Pediatric Hematology, Oncology, and Bone Marrow Transplant, added: 'When a child enters the bone marrow transplant unit, the road ahead can seem so long and difficult. My hope is that, through 'Colors of Hope,' initiative every child and their family finds in these paintings a source of happiness, strength, and inspiration. These aren't just images on walls, they tell a story of renewed potential, opening a door to laughter and light even in the hardest times. We are here to heal their bodies, and with compassion and creativity, we care for their spirits as well.' At Yas Clinic Hospital and Abu Dhabi Stem Cells Center, "Colors of Hope" is a daily celebration of the limitless possibilities that reside within every child. About Abu Dhabi Stem Cells Center (ADSCC) Abu Dhabi Stem Cells Center (ADSCC) is a renowned healthcare institution in Abu Dhabi, UAE, specialising in advanced stem cell therapy, research, and regenerative medicine. ADSCC is the incubator of the Abu Dhabi Bone Marrow Transplant (AD-BMT©) program, the first comprehensive programme to provide autologous and allogeneic hematopoietic stem cells transplant (HSCT) for adult and paediatric patients in the UAE since 2020. As a Center of Excellence in Hematopoietic Stem Cell Transplantation accredited by the Department of Health - Abu Dhabi, ADSCC's holistic service model includes advanced research, clinical trials, translational care, and manufacturing capabilities. ADSCC has one of the region's most advanced and sophisticated research labs and a robust multidisciplinary hospital. It is the only center in the UAE to encompass a cell processing laboratory, a state-of-the-art apheresis unit, a stem cell collection unit, a Good Manufacturing Practice (GMP) laboratory, and dedicated multi-specialty outpatient clinics and inpatient wards. As the UAE's first and most experienced stem cell transplant center, ADSCC has received multiple prestigious recognitions and conducted strategic collaborations, solidifying its position as a center of excellence. In 2024, ADSCC received accreditation from the Foundation for the Accreditation of Cellular Therapy (FACT) for its cellular therapy processing laboratory, the first in UAE and one of only two in Middle East to receive this global accreditation.
